Cellectis CLLS
NASDAQ CLLS
$1.51 +0.04 (+2.72%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cellectis (CLLS) Share-based Compensation (IS) (2015 - 2017)

Updated

Cellectis (CLLS) posted Share-based Compensation (IS) of -$987,000 for FY2022, compared with -$3.6 million in FY2021.

Analysis

Cellectis (CLLS) Share-based Compensation (IS) (2015 - 2017) Analysis & Trends

Since FY2015, Cellectis has reported Share-based Compensation (IS) for 8 years.

  • The FY2022 figure stands as the highest annual Share-based Compensation (IS) in data going back to FY2015.
  • Business Quant data shows CLLS's Share-based Compensation (IS) at -$3.6 million in FY2021, -$2.51 million in FY2020, -$7.83 million in FY2019 and -$8.07 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Cellectis 147.50 Mn -605.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 12.41 Mn
Mar 31, 2017 13.62 Mn
Jun 30, 2016 16.25 Mn
Mar 31, 2016 14.80 Mn
Sep 30, 2015 10.53 Mn
API Access

Cellectis Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CLLS&period=max&api_key=YOUR_API_KEY